Literature DB >> 30641068

Effects of Intraoperative Fluid Management on Postoperative Outcomes After Lobectomy.

Yihe Wu1, Rong Yang2, Jinming Xu1, Aizemaiti Rusidanmu1, Xiongxin Zhang3, Jian Hu4.   

Abstract

BACKGROUND: The amount and type of intraoperative fluid in patients with pulmonary resection currently are controversial. This study evaluated the dose-response relationship between intraoperative fluid administration and postoperative outcomes in minimally invasive lobectomy patients.
METHODS: A retrospective analysis of adult patients undergoing minimally invasive lobectomy between May 2016 and April 2017 was performed. The primary exposure variables were intraoperative total fluid infusion rate and intraoperative colloid infusion rate. The observation outcomes were postoperative pulmonary complications (PPCs), acute kidney injury, in-hospital mortality, postoperative length of stay, and costs. Univariate analyses and multivariate analyses were performed.
RESULTS: In 446 patients all resections were minimally invasive lobectomies. Two hundred one PPCs were observed in 172 patients. Binary logistics regression analysis demonstrated that compared with the moderate group of intraoperative total fluid infusion rate, the risk for PPCs was significantly increased at restrictive (odds ratio [OR], 2.202; 95% confidence interval [CI], 1.189-4.078; p = 0.012), moderately liberal (OR, 2.743; 95% CI, 1.451-5.184; p = 0.002), and liberal (OR, 2.609; 95% CI, 1.278-5.328; p = 0.008) groups. Compared with the moderate group of intraoperative colloid infusion rate, the risk for PPCs significantly increased at no colloid (OR, 2.095; 95% CI, 1.193-3.680; p = 0.010) and restrictive (OR, 2.911; 95% CI, 1.443-5.873; p = 0.003) groups.
CONCLUSIONS: In patients undergoing minimally invasive lobectomy the infusion rates of intraoperative total fluid and intraoperative colloid were all significantly associated with PPCs. Both restrictive and liberal intraoperative fluid administration were related to adverse effects on postoperative outcomes.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30641068     DOI: 10.1016/j.athoracsur.2018.12.013

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Importance of intraoperative fluid management.

Authors:  Hisashi Iwata
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

2.  Perioperative fluid balance and 30-day unplanned readmission after lung cancer surgery: a retrospective study.

Authors:  Tak Kyu Oh; Kwanmien Kim; Jin-Hee Kim; Sung-Hee Han; Jung-Won Hwang
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

3.  Developing a minimally-invasive anaesthesiological approach to non-intubated uniportal video-assisted thoracoscopic surgery in minor and major thoracic surgery.

Authors:  Henning Starke; Norman Zinne; Andreas Leffler; Patrick Zardo; Jan Karsten
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

4.  Prospective comparison of the effects of intraoperative goal-directed fluid therapy and restrictive fluid therapy on complications in thoracoscopic lobectomy.

Authors:  Min Li; Mingqing Peng
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

5.  Effects of preoperative pulmonary function on short-term outcomes and overall survival after video-assisted thoracic surgery lobectomy.

Authors:  Yihe Wu; Yuwei Zhou; Shenhu Gao; Chengli Du; Linpeng Yao; Rong Yang
Journal:  Ann Transl Med       Date:  2021-11

6.  Effects of 24-hour postoperative intravenous fluid on postoperative outcomes after lobectomy: a retrospective observational study.

Authors:  Rong Yang; Yuwei Zhou; Shenhu Gao; Chengli Du; Yihe Wu
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

7.  Risk factors and socio-economic burden in pancreatic ductal adenocarcinoma operation: a machine learning based analysis.

Authors:  Yijue Zhang; Sibo Zhu; Zhiqing Yuan; Qiwei Li; Ruifeng Ding; Xunxia Bao; Timing Zhen; Zhiliang Fu; Hailong Fu; Kaichen Xing; Hongbin Yuan; Tao Chen
Journal:  BMC Cancer       Date:  2020-11-27       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.